Trioday 300 mg/300 mg/600 mg (Lamivudine/Tenofovir/Efavirenz) Quantity:30 Tablet/s Children: Dose based on weight—1–3

Children: Dose based on weight—1–3 tablets per dose following the same 6‑dose schedule :contentReference[oaicite:11]{index=11}

Most patients experience measurable reductions in LDL cholesterol within 2 to 4 weeks of consistent daily use

and endocrine signaling

Sefdin can be taken with or without food

resistance mutations can develop if therapy is not adhered to consistently

Trioday 300 mg/300 mg/600 mg (Lamivudine/Tenofovir/Efavirenz) Quantity:30 Tablet/s Children: Dose based on weight—1–3Product Overview Trioday 300 mg 300 mg 600 mg is a fixeddose antiretroviral tablet produced by Cipla Limited. Each bottle contains 30 tablets and is indicated for the treatment of HIV infection in adults. The formulation combines lamivudine 300 mg, tenofovir disoproxil fumarate 300 mg, and efavirenz 600 mg in a single dose, offering a streamlined regimen for patients who require combination therapy. What is Trioday? Trioday belongs to the class of